AÖAyşe Ceren Öztürk

Ayşe Ceren Öztürk

*This is an algorithmically generated author record based on publicly available information.

Ayşe Ceren Öztürk has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and etiological profile of diplopia in a tertiary neurology clinic

    by Yıldız Arslan, Ayşe Ceren Öztürk, Behice Bircan, Yeliz Çiftçi, Bedile Irem Tiftikçioglu

    Aims: Diplopia is a common neuro-ophthalmological symptom with a wide etiological spectrum involving cranial nerves, the neuromuscular junction, extraocular muscles, and orbital structures. This study aimed to evaluate the clinical characteristics and etiological distribution of patients presenting with diplopia in a tertiary neurology setting.Methods: In this retrospective observational study, 55 patients evaluated for diplopia between January 2023 and August 2025 were analyzed. Demographic data, medical history, neurological and ophthalmological examination findings, laboratory results, neuroimaging, and electrophysiological studies were reviewed.Results: The mean age of the patients was 59±14.2 years, and 52.7% were female. Myasthenia gravis (MG) was the most common etiology (27.27%), followed by microvascular causes (20%) and idiopathic intracranial hypertension (IIH) (16.36%). Other causes included cerebrovascular diseases (14.54%), idiopathic cases (7.27%), multiple sclerosis (7.27%), and single cases of Miller–Fisher syndrome, intracerebral lymphoma, cavernous sinus thrombosis and pontin tumor (1.81% for each). Among the patient population, diabetes mellitus (DM) was diagnosed in 21 individuals and HT in 15. Thyroid function tests and C-reactive protein levels were within normal limits in all patients.Conclusion: The etiology of diplopia varies widely depending on clinical context and patient selection. In this cohort, MG was the leading cause, potentially reflecting referral patterns of a tertiary neurology center, where the diagnostic value and feasibility of single-fiber EMG were prominently demonstrated. The high prevalence of DM highlights diplopia as a potential early indicator of underlying metabolic dysfunction. Early diagnosis and targeted management are essential to improve clinical outcomes.

  • Screening for Paroxysmal Atrial Fibrillation with Smart Devices in Hospitalized Patients with Stroke or Transient Ischemic Event

    by Ahmet Anıl Başkurt, Ferhat Siyamend Yurdam, Sevinj Namazova, Eren Ozan Bakır, Yusuf Demir, Ayşe Ceren Öztürk, Yeliz Çiftçi, Oktay Şenöz

    Background   Cardioembolism in stroke and transient ischemic attack (TIA) patients is highly influenced by atrial fibrillation (AF). The best timing, duration, location (outpatient or inpatient), and procedure for diagnosing paroxysmal atrial fibrillation (PAF) after stroke / TIA are unknown. We investigated the use of smart devices in the detection of PAF during the index event hospitalization. Material and methods   Stroke and TIA patients hospitalized in the neurology service were evaluated. Patients with AF detected on the ECG at emergency department admission and patients with known AF were excluded from the study. Smartphone-based apps were given to 342 other patients to utilize the mobile app on smart devices during follow-up. Three cardiologists reviewed all smart device rhythm electrographs and identified patients with AF. On the basis of concurrent 24–72 h Holter rhythm monitoring, the patients were separated into those who had PAF (n=85; group 1) and those who did not have PAF (n=245; group 2). Results Left atrium size (LA), arterial hypertension, lowest and highest heart rate on the smart device and episodes of AF on the smart device differed between patients with and without PAFas noted on the 24–72 h Holter rhythm recordings. Detection of AF on the smart device was found to be an independent predictor of PAF as observed on the Holter rhythm recording (p=0.017). An AF episode identified on the smart device predicted the detection of PAF on the Holter 24–72 h rhythm recording with 58 % sensitivity and 87 % specificity. (AUC=0.723, 95 % CI=0.569–0.876, p=0.007) Conclusion The detection of PAF following acute ischemic stroke or TIA may be significantly improved during hospitalization by continuously monitoring cardiac rhythm with smart devices.